Does rifaximin decrease small intestinal bacterial overgrowth in patients with irritable bowel syndrome? : Evidence-Based Practice

Secondary Logo

Journal Logo

HELPDESK ANSWERS

Does rifaximin decrease small intestinal bacterial overgrowth in patients with irritable bowel syndrome?

Wright, Kent MD; Middleton, Paul MD; Hudson, Jonell PharmD, BCPS; Coulter, Lois PharmD, BCPS; Vaughn, Brittany MD

Author Information
Evidence-Based Practice 24(11):p 35-36, November 2021. | DOI: 10.1097/EBP.0000000000001333
Copyright © 2021 by Family Physicians Inquiries Network, Inc.

You can read the full text of this article if you:

Access through Ovid